Bridging the gap between breakthrough research and real-world clinical application—accelerating the path from innovation to patient impact.
FRD Accel is a medical technology accelerator based in Charleston, South Carolina, operating in affiliation with the Medical University of South Carolina (MUSC). We partner with researchers, clinicians, and life science innovators to transform breakthrough technologies into clinical and commercial success.
Our team brings together deep expertise in medtech development, regulatory strategy, clinical validation, and commercialization. We work at every stage of the innovation lifecycle—from early-stage concept refinement through market entry—ensuring that promising medical technologies reach the patients who need them.
Founded on the belief that great science deserves a clear path to impact, FRD Accel exists to close the gap between discovery and delivery in healthcare.
Empowering medical technology innovators to transform discoveries into patient-ready solutions. We provide the strategic guidance, clinical expertise, and commercialization support needed to bring life-changing technologies to market.
Advancing healthcare through impactful innovation and strategic collaboration. We envision a future where promising medical breakthroughs move efficiently from the lab to the bedside, improving outcomes for patients worldwide.
Three integrated pillars working together to bring medical technologies from concept to commercial impact.
Driving market and product pathways for emerging medical technologies. We help innovators define their value proposition, navigate regulatory requirements, and build a clear roadmap to market entry and sustainable growth.
Ensuring clinical relevance and efficacy at every stage. Our team works alongside clinical experts to design validation strategies, manage investigational studies, and generate the evidence needed to support adoption.
Building strategic alliances to accelerate adoption. We connect innovators with healthcare systems, industry partners, and investment opportunities that can take their technologies further, faster.
FRD Accel operates in affiliation with the Medical University of South Carolina, one of the nation's leading academic health systems. This partnership provides a direct connection to world-class research, clinical expertise, and a robust innovation ecosystem.
Through our relationship with MUSC and the Zucker Institute for Innovation Commercialization, we advance innovations originating from translational research, supporting their journey through commercialization and venture development.
Whether you're in early research or preparing for commercialization, our team is ready to help you move forward with clarity and confidence.